Ten black/C mice were divided into two groups according to the random number table: control group and experimental group, with five mice in each group. In both groups, CT26 cells in the logarithmic growth phase were inoculated into the spleen to establish a mouse model of CRC. Mice in the control group: 0.3 mL of normal saline was intragastrically administered per day; mice in the experimental group: 0.2 mL of GQD was intragastrically administered per day at a ratio of 0.2 g of medicinal materials/10 g; both groups were intragastrically administered once a day for 10 days and sacrificed and pathological sections were made. Enzyme-linked immunosorbent assay kit was used for both groups of sections (preparation method: known antigens or antibodies were adsorbed on the surface of solid phase carrier (i.e. polystyrene microreaction plate), so that the enzyme-labeled antigen-antibody reaction was performed here. The free components in the liquid phase were removed by washing method). The expression of PI3K/AKT/FOXO1 signaling pathway was detected, and the expression of the ABTB1 gene was also detected by real-time quantitative PCR (extraction and quality detection of total RNA⟶synthesis of cDNA by reverse transcription reaction⟶PCR reaction⟶result analysis) Finally, the rectal cancer cells in the two groups of mice were subjected to scratch assay and transwell assay (steps: preparation of transwell chamber⟶preparation of cell suspension⟶inoculation of cells⟶statistics of results) to observe the expression of p-PI3K, p-AKT, p-FOXO1, and ABTB1 in mice.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.